Cancer Gene Profiling in Non-Small Cell Lung Cancers Reveals Activating Mutations in JAK2 and JAK3 With Therapeutic Implications

Genome Medicine - United Kingdom
doi 10.1186/s13073-017-0478-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hot Spot Mutations in Finnish Non-Small Cell Lung Cancers

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2016English

Profiling Cancer Testis Antigens in Non–small-Cell Lung Cancer

JCI insight
Medicine
2016English

HER2 Mutations in Chinese Patients With Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer With Activating EGFR Mutations

OncoTargets and Therapy
OncologyPharmacology
2016English

OA 05.03 Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients With EGFR Activating and T790M Mutations

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

P1.04-03 Suppressive Immune Cell Profiling in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Pathobiological Implications of MUC4 in Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib

Yearbook of Pulmonary Disease
2006English

Non-Small Cell Lung Cancer: Therapeutic and Evolutionary Aspects in Cote D’Ivoire

Advances in Lung Cancer
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy